Paying users zone. Data is covered by .

  • Get to Biogen Inc. for $15.99, or

  • get to whole website for at least 3 months from $49.99.

 

$15.99


Investment Accounting Policy

Marketable Debt Securities

Available-for-sale debt securities are recorded at fair market value and unrealized gains and losses are included in accumulated other comprehensive income (loss) in equity, net of related tax effects, unless the security has experienced a credit loss, Biogen has determined that Biogen has the intent to sell the security or Biogen has determined that it is more likely than not that Biogen will have to sell the security before its expected recovery. Realized gains and losses are reported in other income (expense), net, on a specific identification basis.

Marketable Equity Securities

Biogen's marketable equity securities represent investments in publicly traded equity securities and are included in investments and other assets in the consolidated balance sheets. When assessing whether a decline in the fair value of a marketable equity security is other-than-temporary, Biogen considers the fair market value of the security, the duration of the security's decline and prospects for the underlying business, including favorable or adverse clinical trial results, new product initiatives and new collaborative agreements with the companies in which Biogen has invested.

Source: Biogen Inc., Annual Report

Top


Adjustment to Net Income (Loss): Mark to Market Available-for-sale Securities

Biogen Inc., adjustment to Net Income Attributable To Biogen Inc.

USD $ in thousands

 
12 months ended Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Net income attributable to Biogen Inc. (as reported)
Add: Unrealized gains (losses) on securities available for sale, net of tax
Net income attributable to Biogen Inc. (adjusted)

Top


Adjusted Ratios: Mark to Market Available-for-sale Securities (Summary)

Biogen Inc., adjusted ratios

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Net Profit Margin
Reported net profit margin % % % % %
Adjusted net profit margin % % % % %
Return on Equity (ROE)
Reported ROE % % % % %
Adjusted ROE % % % % %
Return on Assets (ROA)
Reported ROA % % % % %
Adjusted ROA % % % % %
Ratio Description The company
Adjusted net profit margin An indicator of profitability, calculated as adjusted net income divided by revenue. Biogen Inc.'s adjusted net profit margin deteriorated from 2015 to 2016 and from 2016 to 2017.
Adjusted ROE A profitability ratio calculated as adjusted net income divided by shareholders' equity. Biogen Inc.'s adjusted ROE deteriorated from 2015 to 2016 and from 2016 to 2017.
Adjusted ROA A profitability ratio calculated as adjusted net income divided by total assets. Biogen Inc.'s adjusted ROA deteriorated from 2015 to 2016 and from 2016 to 2017.

Top


Adjusted Net Profit Margin

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
As Reported
Net income attributable to Biogen Inc. (USD $ in thousands)
Revenues (USD $ in thousands)
Net profit margin1 % % % % %
Adjusted: Mark to Market Available-for-sale Securities
Adjusted net income attributable to Biogen Inc. (USD $ in thousands)
Revenues (USD $ in thousands)
Adjusted net profit margin2 % % % % %

2017 Calculations

1 Net profit margin = 100 × Net income attributable to Biogen Inc. ÷ Revenues
= 100 × ÷ = %

2 Adjusted net profit margin = 100 × Adjusted net income attributable to Biogen Inc. ÷ Revenues
= 100 × ÷ = %

Ratio Description The company
Adjusted net profit margin An indicator of profitability, calculated as adjusted net income divided by revenue. Biogen Inc.'s adjusted net profit margin deteriorated from 2015 to 2016 and from 2016 to 2017.

Top


Adjusted Return on Equity (ROE)

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
As Reported
Net income attributable to Biogen Inc. (USD $ in thousands)
Total Biogen Inc. shareholders' equity (USD $ in thousands)
ROE1 % % % % %
Adjusted: Mark to Market Available-for-sale Securities
Adjusted net income attributable to Biogen Inc. (USD $ in thousands)
Total Biogen Inc. shareholders' equity (USD $ in thousands)
Adjusted ROE2 % % % % %

2017 Calculations

1 ROE = 100 × Net income attributable to Biogen Inc. ÷ Total Biogen Inc. shareholders' equity
= 100 × ÷ = %

2 Adjusted ROE = 100 × Adjusted net income attributable to Biogen Inc. ÷ Total Biogen Inc. shareholders' equity
= 100 × ÷ = %

Ratio Description The company
Adjusted ROE A profitability ratio calculated as adjusted net income divided by shareholders' equity. Biogen Inc.'s adjusted ROE deteriorated from 2015 to 2016 and from 2016 to 2017.

Top


Adjusted Return on Assets (ROA)

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
As Reported
Net income attributable to Biogen Inc. (USD $ in thousands)
Total assets (USD $ in thousands)
ROA1 % % % % %
Adjusted: Mark to Market Available-for-sale Securities
Adjusted net income attributable to Biogen Inc. (USD $ in thousands)
Total assets (USD $ in thousands)
Adjusted ROA2 % % % % %

2017 Calculations

1 ROA = 100 × Net income attributable to Biogen Inc. ÷ Total assets
= 100 × ÷ = %

2 Adjusted ROA = 100 × Adjusted net income attributable to Biogen Inc. ÷ Total assets
= 100 × ÷ = %

Ratio Description The company
Adjusted ROA A profitability ratio calculated as adjusted net income divided by total assets. Biogen Inc.'s adjusted ROA deteriorated from 2015 to 2016 and from 2016 to 2017.

Top